Glucagon is a hormone that stimulates the breakdown of glycogen stores in the liver into glucose, and this is decreased by GLPs
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes SIGN UP FREE Keywords l-cell,intestine,gi,gastrointestinal,intestinal,enterocyte,columnar cell,ciliated,epithelial cell,mesenchymal cell,healing,wound,fibrosis,glp-1,l-cell,release,releasing,secretion,secrete,secreting,enteroendocrine cell,intestinal cell,gut cell,hormone-secreting cell,incretin-producing cell,glp-1 cell,glucagon-like peptide-1,glp-1 secretion,gut epithelium,intestinal epithelium,endocrine cell,gastrointestinal tract,gi tract,colon,small intestine cell,gut hormone,nutrient-sensing,epithelial cell,hormone-producing cell,intestinal endocrine system,metabolic regulation,cellular hormone release,gut microbiome interaction,l-cell biology,digestive system,glucose homeostasis,postprandial hormone,cell type intestine,cell type endocrine,mucosal cell,type 2 diabetes research,obesity research,metabolic disease research,gastroenterology,endocrinology,nutrient signalling,gut-brain axis,microbiome research,glucose metabolism,appetite regulation,incretin biology,diabetes therapy development,bariatric surgery studies,hormone signalling pathways,intestinal physiology,nutritional science,pharmaceutical research,cell signalling studies,neuroendocrine system research,targeted drug delivery,biomedical research,clinical research,translational medicine
B.ButcherA
This research-grade peptide is studied for upregulation of BDNF and NGF expression in hippocampal and cortical tissues, modulation of monoaminergic systems (dopamine, serotonin, noradrenaline), and neuroprotection in cerebral ischemia models
Related links ClinicalTrials.gov: EU Clinical Trials register: Rights and permissions About this article Cite this article Kivel, L., Caminero, A., Leffler, D.A
